Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Investigation of Genetic Risk of Cardiovascular Disease in Prospective Cohort Study

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2007 by Nagoya University.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
Aichi Gakuin University
Information provided by:
Nagoya University
ClinicalTrials.gov Identifier:
NCT00262691
First received: December 6, 2005
Last updated: September 20, 2007
Last verified: September 2007
  Purpose
Cardiovascular disease is a complex multifactorial and polygenic disorder that is thought to result from an interaction between a person's genetic make up and various environmental factors. Although many studies have revealed that several genetic variants increase the risk of cardiovascular disease, the results of these studies remain controversial. The purpose of this study is to identify polymorphisms that confer susceptibility to cardiovascular disease and to clarify the adequacy of reported susceptibility gene polymorphisms. To complete this purpose, we will prospectively study over 5,000 local residents in whom relationship between these polymorphisms and occurrence of cardiovascular disease over 5 years.

Condition
Healthy
Coronary Disease
Myocardial Infarction
Cerebral Infarction

Study Type: Observational
Study Design: Observational Model: Case Control
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Investigation of Genetic Risk of Cardiovascular Disease in Prospective Cohort Study, the Kitanagoya Genome (KING) Study for the Local Residents of Kitanagoya, Japan

Further study details as provided by Nagoya University:

Estimated Enrollment: 7000
Study Start Date: May 2005
  Eligibility

Ages Eligible for Study:   50 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Healthy subjects who undergo community-based annual health check in Kitanagoya city
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00262691

Locations
Japan
Department of Genome Science, School of Dentistry, Aichi-Gakuin University
Nagoya, Aichi, Japan, 464-8651
Sponsors and Collaborators
Nagoya University
Aichi Gakuin University
Investigators
Study Chair: Mitsuhiro Yokota, MD, PhD Department of Genome Science, School o Dentistry, Aichi-Gakuin University
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00262691     History of Changes
Other Study ID Numbers: NU-05-G-0001 
Study First Received: December 6, 2005
Last Updated: September 20, 2007
Health Authority: Japan: Ministry of Health, Labor and Welfare

Additional relevant MeSH terms:
Infarction
Cardiovascular Diseases
Myocardial Infarction
Coronary Disease
Coronary Artery Disease
Cerebral Infarction
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases
Vascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Brain Infarction
Brain Ischemia
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Stroke

ClinicalTrials.gov processed this record on December 07, 2016